Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Cytokineticscytokinetics.com · Low evidenceCytokinetics is a late-stage biopharmaceutical company focused on developing small molecule muscle activators and inhibitors for diseases of impaired muscle function, including heart failure and hypertrophic cardiomyopathy. The company received FDA approval for its first medicine in 2025, advancing its goal of improving healthspan for patients with cardiovascular and neuromuscular conditions.
Parse Score